Skip to main content
SpringerLink
Log in

Surgical Prevention

  • Chapter
  • First Online:
Book cover Breast Cancer

  • 125k Accesses

Abstract

The surgical strategies available today for breast cancer prevention are prophylactic bilateral or unilateral mastectomy and prophylactic bilateral salpingo-oophorectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Tuttle TM, Habermann EB, Grund EH et al (2007) Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol 25:5203–5209

    Article  PubMed  Google Scholar 

  2. Kurian AW, Lichtensztajn DY, Keegan TH et al (2014) Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998–2011. JAMA 312(9):902–914

    Article  CAS  PubMed  Google Scholar 

  3. Yao K, Stewart AK, Winchester DJ et al (2010) Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998–2007. Ann Surg Oncol 17:2554–2562

    Article  PubMed  Google Scholar 

  4. Fehniger J, Livaudais-Toman J, Karliner L et al (2014) Perceived versus objective breast cancer risk in diverse women. J Womens Health (Larchmt) 23(5):420–427

    Article  Google Scholar 

  5. Banegas MP, Püschel K, Martínez-Gutiérrez J et al (2012) Perceived and objective breast cancer risk assessment in Chilean women living in an underserved area. Cancer Epidemiol Biomark Prev 21(10):1716–1721

    Article  Google Scholar 

  6. Barton MB, West CN, Liu IL et al (2005) Complications following bilateral prophylactic mastectomy. J Natl Cancer Inst Monogr 35:61–66

    Article  Google Scholar 

  7. Miller ME, Czechura T, Martz B et al (2013) Operative risks associated with contralateral prophylactic mastectomy. Ann Surg Oncol 20(13):4113–4120

    Article  PubMed  Google Scholar 

  8. Bresser PJ, Seynaeve C, Van Gool AR et al (2006) Satisfaction with prophylactic mastectomy and breast reconstruction in genetically predisposed women. Plast Reconstr Surg 117(6):1675–1684

    Article  CAS  PubMed  Google Scholar 

  9. Frost MH, Schaid DJ, Sellers TA et al (2000) Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA 284(3):319–324

    Article  CAS  PubMed  Google Scholar 

  10. Guiliano AE, Boolbol S, Degnim A et al (2007) Society of surgical oncology: position statement on prophylactic mastectomy. Ann Surg Oncol 14:2425–2427

    Article  Google Scholar 

  11. Tuttle TM, Jarosek S, Habermann E et al (2009) Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol 27:1362–1367

    Article  PubMed  Google Scholar 

  12. McLaughlin CC, Lillquist PP, Edge SB et al (2009) Surveillance of prophylactic mastectomy: trends in use from 1995 through 2005. Cancer 115:5404–5412

    Article  PubMed  Google Scholar 

  13. Sorbero ME, Dick AW, Burke Beckjord E et al (2009) Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol 16:1597–1605

    Article  PubMed  Google Scholar 

  14. Jones NB, Wilson J, Kotur L et al (2009) Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol 16:2691–2696

    Article  PubMed  Google Scholar 

  15. King TA, Sakr R, Patil S et al (2011) Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol 29:2158–2164

    Article  PubMed  Google Scholar 

  16. Lostumbo L, Carbine NE, Wallace J (2010) Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev. doi:10.1002/14651858.CD002748

    PubMed  Google Scholar 

  17. Bedrosian I, Hu CY, Chang GJ et al (2010) Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst 102:1–9

    Google Scholar 

  18. Boughey J, Hoskin TL, Degnim AC et al (2010) Contralateral prophylactic mastectomy is associated with a survival advantage in high risk women with a personal history of breast cancer. Ann Surg Oncol 17:2702–2709

    Article  PubMed  PubMed Central  Google Scholar 

  19. Basu NN, Barr L, Ross GL et al (2015) Contralateral risk-reducing mastectomy: review of risk factors and risk-reducing strategies. Int J Surg Oncol 2015:901046

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Yao K, Winchester DJ, Czechura T et al (2013) Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998–2002. Breast Cancer Res Treat 142(3):465–476

    Article  PubMed  Google Scholar 

  21. Fayanju OM, Stoll CR, Fowler S et al (2014) Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysis. Ann Surg 260(6):1000–1010

    Article  PubMed  PubMed Central  Google Scholar 

  22. Basu NN, Ross GL, Evans DG et al (2015) The Manchester guidelines for contralateral risk-reducing mastectomy. World J Surg Oncol 13:237

    Article  PubMed  PubMed Central  Google Scholar 

  23. Mavaddat N, Peock S, Frost D, Ellis S, Platte R, Fineberg E et al (2013) Cancer risks for BRCA1 and BRCA2 mutation carriers: results from a prospective analysis of EMBRACE. J Natl Cancer Inst 105(11):812–822

    Article  CAS  PubMed  Google Scholar 

  24. Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25:1329–1333

    Article  PubMed  PubMed Central  Google Scholar 

  25. Hartmann LC, Sellers TA, Schaid DJ et al (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93:1633–1637

    Article  CAS  PubMed  Google Scholar 

  26. Domchek SM, Friebel TM, Singer CF et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304(9):967–975

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Heemskerk-Gerritsen BA, Menke-Pluijmers MB, Jager A et al (2013) Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis. Ann Oncol 24(8):2029–2035

    Article  CAS  PubMed  Google Scholar 

  28. Skytte AB, Crüger D, Gerster M et al (2011) Breast cancer after bilateral risk-reducing mastectomy. Clin Genet 79:431–437

    Article  PubMed  Google Scholar 

  29. De Felice F, Marchetti C, Musella A et al (2015) Bilateral risk-reduction mastectomy in BRCA1 and BRCA2 mutation carriers: a meta-analysis. Ann Surg Oncol 22(9):2876–2880

    Article  PubMed  Google Scholar 

  30. Petit JY, Veronesi U, Orecchia R et al (2009) Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: one thousand and one cases of a five years experience at the European institute of oncology of Milan (EIO). Breast Cancer Res Treat 117:333–338

    Article  CAS  PubMed  Google Scholar 

  31. Petit JY, Veronesi U, Lohsiriwat V et al (2011) Nipple-sparing mastectomy—is it worth the risk? Nat Rev Clin Oncol 8:742–747

    Article  PubMed  Google Scholar 

  32. Petit JY, Veronesi U, Orecchia R et al (2012) Risk factors associated with recurrence after nipple-sparing mastectomy for invasive and intraepithelial neoplasia. Ann Oncol 23:2053–2058

    Article  CAS  PubMed  Google Scholar 

  33. Manning AT, Sacchini VS (2016) Conservative mastectomies for breast cancer and risk-reducing surgery: the memorial Sloan Kettering cancer center experience. Gland Surg 5(1):55–62

    PubMed  PubMed Central  Google Scholar 

  34. Van Verschuer VM, Maijers MC, van Deurzen CH et al (2015) Oncological safety of prophylactic breast surgery: skin-sparing and nipple-sparing versus total mastectomy. Gland Surg 4(6):467–475

    PubMed  PubMed Central  Google Scholar 

  35. Toesca A, Peradze N, Galimberti V et al (2015) Robotic nipple-sparing mastectomy and immediate breast reconstruction with implant: first report of surgical technique. Ann Surg 7. [Epub ahead of print]

    Google Scholar 

  36. Breast cancer risk reduction, NCCN guidelines Version 1.2016

    Google Scholar 

  37. Nagaraja V, Edirimanne S, Eslick GD (2016) Is sentinel lymph node biopsy necessary in patients undergoing prophylactic mastectomy? A systematic review and meta-analysis. Breast J. doi:10.1111/tbj.12549. [Epub ahead of print]

    PubMed  Google Scholar 

  38. Rebbeck TR, Levin AM, Eisen A et al (1999) Breast cancer risk after bilateral prophylacticoophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst 91(17):1475–1479

    Article  CAS  PubMed  Google Scholar 

  39. Rebbeck TR, Lynch HT, Neuhausen SL et al (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346(21):1616–1622

    Article  PubMed  Google Scholar 

  40. Eisen A, Lubinski J, Klijn J et al (2005) Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. J Clin Oncol 23:7491–7496

    Article  PubMed  Google Scholar 

  41. Kramer JL, Velazquez IA, Chen BSE et al (2005) Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers. J Clin Oncol 23(34):8629–8635

    Article  PubMed  Google Scholar 

  42. Domchek SM, Friebel TM, Neuhausen SL et al (2006) Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Lancet Oncol 7(3):223–229

    Article  CAS  PubMed  Google Scholar 

  43. Kauff ND, Domchek SM, Friebel TM et al (2008) Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. J Clin Oncol 26(8):1331–1337

    Article  PubMed  PubMed Central  Google Scholar 

  44. Heemskerk-Gerritsen BA, Seynaeve C, van Asperen CJ et al (2015) Hereditary Breast and Ovarian Cancer Research Group Netherlands. Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction. J Natl Cancer Inst 107(5):djv033

    Google Scholar 

  45. Loman N, Johannsson O, Bendahl PO et al (1998) Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes. Cancer 83(2):310–319

    Article  CAS  PubMed  Google Scholar 

  46. Honrado E, Benítez J, Palacios J et al (2006) Histopathology of BRCA1- and BRCA2-associated breast cancer. Crit Rev Oncol Hematol 59(1):27–39

    Article  PubMed  Google Scholar 

  47. Hartmann LC, Lindor NM (2016) The role of risk-reducing surgery in hereditary breast and ovarian cancer. N Engl J Med 374(5):454–468

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Breast Surgery, European Institute of Oncology, University of Milan, 20141, Milan, Italy

    Paolo Veronesi

  2. Division of Breast Surgery, European Institute of Oncology, 20141, Milan, Italy

    Nickolas Peradze

Authors
  1. Paolo Veronesi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nickolas Peradze
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paolo Veronesi .

Editor information

Editors and Affiliations

  1. European Institutee of Oncology, Milan, Italy

    Umberto Veronesi

  2. European Institute of Oncology, Milan, Italy

    Aron Goldhirsch

  3. European Institute of Oncology, Milan, Italy

    Paolo Veronesi

  4. San Raffaele University and Research Hospital, Milano, Italy

    Oreste Davide Gentilini

  5. European Institute of Oncology, Milan, Italy

    Maria Cristina Leonardi

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Veronesi, P., Peradze, N. (2017). Surgical Prevention. In: Veronesi, U., Goldhirsch, A., Veronesi, P., Gentilini, O., Leonardi, M. (eds) Breast Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-48848-6_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-48848-6_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-48846-2

  • Online ISBN: 978-3-319-48848-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation